title: Aspects of current management: orthopaedic surgery in haemophilia.
abstract: If continuous prophylaxis is not feasible due to expense or lack of venous access, we must aggressively treat major haemarthroses (including arthrocentesis) to prevent progression to synovitis, recurrent joint bleeds, and ultimately end-stage osteoarthritis (haemophilic arthropathy). For the treatment of chronic haemophilic synovitis, radiosynovectomy should always be indicated as the first procedure. If, after three procedures with 6-month interval, radiosynovectomy fails, an arthroscopic synovectomy must be indicated. Between the second and fourth decades, many haemophilic patients develop joint destruction (arthropathy). At this stage possible treatments include alignment osteotomy, arthroscopic joint debridement, arthrodesis (joint fusion) and total joint arthroplasty. For the hip press-fit uncemented components (hemispherical acetabulum, flanged femoral stem, metal-to-polyethylene) are recommended whilst for the knee a posterior-stabilized (PS) cemented design is advised. Muscular problems must not be underestimated in haemophilia due to their risk of developing compartment syndromes (which will require surgical decompression) and pseudotumours (which will require surgical removal or percutaneous treatment). Regarding patients with inhibitors, the advent of APCCs and rFVIIa has made major orthopaedic surgery possible, leading to an improved quality of life for haemophilia patients. Concerning local fibrin seal, it is not always necessary to achieve haemostasis in all surgical procedures performed in persons with haemophilia. However, it could be a good adjunct therapy, mainly when a surgical field potentially will bleed more than expected (i.e. patients with inhibitors), and also in some orthopaedic procedures (mainly the surgical removal of pseudotumours).
authors.affiliation: Department of Orthopaedic Surgery, La Paz University Hospital, Madrid and Autónoma University, Madrid, Spain. ecrmerchan@gmx.es
authors.forename: E C
authors.initials: EC
authors.lastname: Rodriguez-Merchan
mesh_terms: D001182:Arthroscopy / Q000379:methods; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D019468:Disease Management; D006395:Hemarthrosis / Q000150:complications / Q000601:surgery; D006467:Hemophilia A / Q000150:complications*; D002836:Hemophilia B / Q000150:complications*; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D011788:Quality of Life; D011878:Radiotherapy / Q000379:methods; D013585:Synovitis / Q000209:etiology / Q000601:surgery
chemical_list: D001779:Blood Coagulation Factors